Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review

Sang Jin Kim, Jong Man Kim

Clin Mol Hepatol. 2022;28(4):739-753. Published online April 26, 2022

DOI: https://doi.org/10.3350/cmh.2022.0060

View: 4299 Download: 157 Web of Science: 7 Crossref: 8

Editorial

Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open

Bo Hyun Kim

Clin Mol Hepatol. 2022;28(2):174-176. Published online January 26, 2022

DOI: https://doi.org/10.3350/cmh.2021.0400

View: 3476 Download: 105 Web of Science: 2 Crossref: 2

Review

The management of post-transplantation recurrence of hepatocellular carcinoma

Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin

Clin Mol Hepatol. 2022;28(1):1-16. Published online October 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0217

View: 7737 Download: 326 Web of Science: 24 Crossref: 27

Original Article

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma

Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo

Clin Mol Hepatol. 2021;27(4):589-602. Published online July 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0038

View: 5685 Download: 241 Web of Science: 18 Crossref: 19

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma

Ching-Chih Lin, Ta-Wei Liu, Ming-Lun Yeh, Yi-Shan Tsai, Pei-Chien Tsai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang, Chia-Yen Dai, Ming-Lung Yu

Clin Mol Hepatol. 2021;27(2):313-328. Published online December 14, 2020

DOI: https://doi.org/10.3350/cmh.2020.0247

View: 10441 Download: 153 Web of Science: 9 Crossref: 7

Letter to the Editor

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?

Bo Hyun Kim

Clin Mol Hepatol. 2020;26(4):579-581. Published online September 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0200

View: 3529 Download: 72 Web of Science: 2 Crossref: 2

Original Article

Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients

Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2020;26(4):516-528. Published online September 11, 2020

DOI: https://doi.org/10.3350/cmh.2020.0016

View: 6074 Download: 207 Web of Science: 40 Crossref: 40

Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial

Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee

Clin Mol Hepatol. 2020;26(4):506-515. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0038

View: 6460 Download: 195 Web of Science: 43 Crossref: 48

Editorial

Long-term prognosis and management of hepatocellular carcinoma after curative treatment

Naoshi Nishida

Clin Mol Hepatol. 2020;26(4):480-483. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0208

View: 5062 Download: 97 Web of Science: 11 Crossref: 11

Original Article

Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization

Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth

Clin Mol Hepatol. 2019;25(1):74-85. Published online February 28, 2019

DOI: https://doi.org/10.3350/cmh.2018.0072

View: 7145 Download: 202 Web of Science: 20 Crossref: 22

Liver Imaging

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma

Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha

Clin Mol Hepatol. 2017;23(1):95-101. Published online March 24, 2017

DOI: https://doi.org/10.3350/cmh.2017.0006

View: 11048 Download: 255 Web of Science: 39 Crossref: 35

Original Article

Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma

Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(4):477-486. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0048

View: 9027 Download: 154 Web of Science: 23 Crossref: 21

Review

Current status of laparoscopic liver resection for hepatocellular carcinoma

Hanisah Guro, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, YoungRok Choi, Mohan Periyasamy

Clin Mol Hepatol. 2016;22(2):212-218. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2016.0026

View: 12908 Download: 287 Web of Science: 54 Crossref: 51

Management of viral hepatitis in liver transplant recipients

Soung Won Jeong, YoungRok Choi, Jin-Wook Kim

Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.338

View: 8426 Download: 80 Web of Science: 3 Crossref: 3

3

Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein Level?

Woo Young Shin, M.D., Kyung-Suk Suh, M.D. Taehoon Kim, M.D. Young Min Jeon, M.D. Nam-Joon Yi, M.D. Kuhn Uk Lee, M.D.

Clin Mol Hepatol. 2010;16(2):168-175. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.168

View: 4414 Download: 19 Crossref: 3

Risk factors for early recurrence after surgical resection for hepatocellular carcinoma

Ui Jun Park, M.D., Yong Hoon Kim, M.D., Koo Jeong Kang, M.D., Tae Jin Lim, M.D.

Clin Mol Hepatol. 2008;14(3):371-380. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.371

View: 5049 Download: 52 Crossref: 12

Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma

Ju Ik Moon, M.D., Jong Man Kim, M.D., Gum Oh Jung, M.D., Jae Min Chun, M.D., Gyu-Seong Choi, M.D., Jae Berm Park, M.D., Choon Hyuck David Kwon, M.D., Sung Joo Kim, M.D., Jae Won Jo, M.D.,

Clin Mol Hepatol. 2008;14(2):185-196. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.185

View: 5150 Download: 44 Crossref: 4

Clinical Outcome after Living Donor Liver Transplantation in Patients with Hepatitis C Virus-associated Cirrhosis

Jeong-Ik Park, M.D. Kun-Moo Choi, M.D. Sung-Gyu Lee, M.D. Shin Hwang, M.D. Ki-Hun Kim, M.D. Chul-Soo Ahn, M.D. Deok-Bog Moon, M.D. Young-Hwa Chung, M.D. Yung-Sang Lee, M.D. Dong-Jin Suh, M.D.

Clin Mol Hepatol. 2007;13(4):543-555. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.543

View: 4667 Download: 17 Crossref: 2

Clinical Outcomes of Lamivudine Therapy in HBeAg Positive Chronic Hepatitis B with Minimally Elevated ALT

Dong Ha Han , Neung Hwa Park , Jung Woo Shin , Seok Won Jung , Young Tae Hwang , Hyun Soo Kim , In Du Jeong , Sung Jo Bang , Do Ha Kim

Clin Mol Hepatol. 2007;13(2):146-156. Published online January 1, 1970

View: 2711 Download: 20

Change of Hepatitis B Virus DNA Status in Anti-HBc Positive Liver Graft

Choon Hyuck Kwon, M.D., Kyung-Suk Suh, M.D., Ph.D., Jai Young Cho, M.D., Nam-Joon Yi, M.D., Ph.D., Ja-June Jang, M.D., Ph.D. and Kuhn Uk Lee, M.D., Ph.D., FACS

Clin Mol Hepatol. 2006;12(2):191-200. Published online January 1, 1970

View: 2740 Download: 23

The Comparative Results of Radiofrequency Ablation versus Surgical Resection for the Treatment of Hepatocellular Carcinoma

Chang-Min Cho, M.D., Won-Young Tak, M.D., Young-Oh Kweon, M.D., Sung-Kook Kim, M.D., Yong-Hwan Choi, M.D., Yoon-Jin Hwang, M.D. and Yang-Il Kim, M.D.

Clin Mol Hepatol. 2005;11(1):59-71. Published online January 1, 1970

View: 3067 Download: 44

Recurrence and Management of Hepatitis C after Liver Transplantation

Ki Bong Oh, M.D., Sung Gyu Lee, M.D., Young Joo Lee, M.D., Kwang Min Park, M.D., Shin Hwang, M.D., Ki Hun Kim, M.D., Chul Soo Ahn, M.D., Deok Bog Moon, M.D., Chong Woo Chu, M.D., Hyun Seung Yang, M.D., Tae Yong Ha, M.D. and Sung Hoon Cho, M.D.

Clin Mol Hepatol. 2003;9(3):180-187. Published online January 1, 1970

View: 2555 Download: 13

4

A Case of Needle Tract Seeding of Hepatocllular Carcinoma after Percutaneous Ethanol Injection Therapy ; Needle Tract Seeding after Percutaneous Ethanol Injection Therapy

Sung Wuk Song, M.D., So Young Kwon, M.D., Yang Wook Kang, M.D., Jin Neyn Kim, M.D., Tae Hoon Kim, M.D., Myoung Oh, M.D., Bong Ki Chung, M.D., Hye Seung Yu, M.D., and Hee Jin Chang, M.D.*

Clin Mol Hepatol. 2001;7(3):325-329. Published online January 1, 2000

View: 2126 Download: 12

A Case of Postoperative Recurrence of Heatocelluar Carcinoma in Pelvic Bone without Intrahepatic Metastasis Eight Year After

Deok-Kyu Cho, M.D., Kwang Hyub Han, M.D., Jae Youn Cheong, M.D., Do Yun Lee, M.D.*, Se Hoon Kim, M.D.†, and Young Nyun Park, M.D.†

Clin Mol Hepatol. 2001;7(3):315-319. Published online January 1, 2000

View: 2720 Download: 13

3

Analysis of Recurrence and Prognostic Factors after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

Min Su Geum, M.D.*, Dae Hyun Kim, M.D., Won Young Tak, M.D. Young Oh Kweon, M.D., Sung Kook Kim, M.D., Yong Hwan Choi, M.D. and Joon Mo Chung, M.D.

Clin Mol Hepatol. 2000;6(1):111-123. Published online January 1, 2000

View: 2194 Download: 14

Difference in Early Postoperative Recurrence Rate of Hepatocellular Carcinoma According to the Imaging Modalities Used for Preoperative Staging : Comparison Between CTAP and CTHA, Lipiodol CT and Three Phase Helical CT

Moon Seok Choi, Seung Woon Paik, Sang Goo Lee, Joon Hyoek Lee, Kwang Cheol Koh, Poong Lyul Rhee, Jae Jun Kim, Jong Chul Rhee and Kyoo Wan Choi

Clin Mol Hepatol. 1998;4(4):358-364. Published online January 1, 2000

View: 1972 Download: 13

Usefulness of Lens Culinaris Agglutinin - A Reactive Alpha - Fetoprotein for the Diagnosis of Hepatocelluar Carcinoma in Patients with Chronic Liver Disease Who Showed Significant Increment of Serum Alpha - Fetoprotein Level and No Mass Lesion in the Liver on Ultrasonogram

June Sung Lee , Jung Hwan Yoon , Hyo Suk Lee , Chung Yong Kim

Clin Mol Hepatol. 1998;4(2):120-130. Published online January 1, 2000

View: 2348 Download: 17

The prognosis and effect of treatment modalities on recurrent hepatocellular carcinoma after curative resection

Chae Yoon Chon , Chan Hee Lee , Kwan Sik Lee , Jun Keun Chung , Kyung Chul Kim , Kwang Hyub Han , Young Myung Moon , In Suh Park , Byung Ro Kim

Clin Mol Hepatol. 1996;2(2):198-208.

View: 2227 Download: 13

Treatment outcome of the patients with small hepatoma ( ≤ 5 cm in diameter ) in relation to treatment modalities and underlying liver function

Kun Hoon Song , Kwang Hyub Han , Young Myung Moon , Chae Yoon Chon , Won Choi , Kwan Sik Lee , In Suh Park , Byong Ro Kim , Jong Tae Lee

Clin Mol Hepatol. 1996;2(2):186-197.

View: 65535 Download: 13

1 |

Viewed By 5256	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5200	MAFLD: How is it different from NAFLD?
Viewed By 5108	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3830	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3764	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search